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A major surface constituent of Echinococcus multilocu-
laris adult worms, referred to as an EmA9 antigen, was
immunoaffinity purified and identified as a high-molecular-
weight glycoconjugate. Labeling studies using the mon-
oclonal antibody MAbEmA9 indicated that this antigen
undergoes a regulated expression during the development
from the larval to the adult parasite. Chemical modification
of carbohydrate by periodate oxidation resulted in a reduced
reactivity with antigen-specific antibodies. Non-reductive β-
elimination of the purified molecule indicated the presence
of O-linked glycans attached to threonine residues. Carbo-
hydrate compositional analyses indicated the presence of N-
and O-glycans with the ratio of carbohydrate to protein be-
ing 1.5:1 (w/w). N- and O-linked glycans were released by
hydrazinolysis and analyzed as 2-aminobenzamide deriva-
tized glycans by mass spectrometry together with HPLC and
enzymatic sequencing. Novel linear O-linked saccharides
with multiple β-HexNAc extensions of reducing end Gal
were identified. N-Linked glycans were also detected with
oligomannose and mono-, bi-, tri- and tetra-antennary-type
structures, most of which were found to be core-fucosylated.
Taken together, the results indicate that the EmA9 antigen
is a glycoprotein located at the outer surface of the adult
E. multilocularis. The observation that the EmA9 antigen
expression is developmentally regulated suggests an involve-
ment of this glycoprotein in the establishment of the parasite
in its canine host.
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Introduction
The cestode Echinococcus multilocularis is the causative agent
of human alveolar echinococcosis, a severe tumor-like parasitic
1To whom correspondence should be addressed: Tel: +41-44-6355104; Fax:
+41-44-6356814; e-mail: a.j.hulsmeier@access.uzh.ch
disease that can be fatal if left untreated (Torgerson et al. 2008).
In common with all other tapeworms, the parasite lacks an intes-
tine and is covered by a syncytial tegument that mediates nutri-
ent uptake and protects against the hosts’ immune response. The
life cycle of E. multilocularis comprises sexually mature, intesti-
nal stages in the definitive host (carnivores), a free-living egg
and the infective larval stage in the intermediate host (rodents)
(Eckert and Deplazes 2004). Humans can be accidentally in-
fected with the parasite by ingestion of eggs containing an on-
cosphere released with feces of the definitive host. Activated
oncospheres penetrate the intestinal mucosa and enter via the
blood circulation various host organs, most commonly the liver,
where it further develops to the metacestode stage. This metaces-
tode is built up of a multivesicular structure surrounded by an
outer laminated layer and an inner germinal epithelium prolifer-
ating in an alveolar pattern. A major constituent of the laminated
layer, the Em2(G11) antigen, has previously been defined as a
mucin-type glycoprotein and suggested to play a major role in
protecting the parasite from immune and other host defense re-
actions (Hu¨lsmeier et al. 2002). Infection of the definitive host
is caused by ingestion of metacestodes that develop within the
small intestine into the adult worm.
In contrast to the metacestode laminated layer, scarce infor-
mation is available about the structure and biological role of
the tapeworm’s adult stage surface constituents. The external
surface coat is a highly dynamic structure with a short turnover
rate. As has been shown for other helminths species (Hokke and
Deelder 2001; Theodoropoulos et al. 2001; Thomas and Harn
2004), the outer membrane glycoconjugates of adult E. multiloc-
ularis may have crucial functions in host-parasite interactions,
such as protecting the parasite by modulating the host’s im-
mune response. On the other hand, glycan determinants within
surface and secreted glycoconjugates principally serve to initi-
ate the immune responses against helminths in infected hosts
(Nyame et al. 2004). Excretory/secretory antigens derived from
axenic cultures of E. multilocularis pre-adult stages were suc-
cessfully applied for the detection of specific antibodies in host
sera, and antibodies raised against these antigens were used for
the development of coproantigen tests (Deplazes et al. 1992;
Morishima et al. 1999).
In the present work, we describe the identification of a
diagnostically relevant antigen, immunoaffinity purified from
E. multilocularis tegument preparations. The biochemical na-
ture of this antigen was not understood previously, and here
we provide the first description of a purification of this
antigen. Biochemical and mass spectrometric characteriza-
tion revealed the presence of a developmentally regulated,
high-molecular-weight glycoprotein, modified by N-linked gly-
cosylation and unique O-galactosyl saccharides linked to
threonine. This work describes a new type of O-glycosylation
in animals.
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Fig. 1. Immunofluorescence staining of adult and larval stages (protoscoleces) of E. multilocularis. The monoclonal antibody EmA9 together with a
FITC-conjugated anti-mouse antibody was used for staining. Left column: bright field microscopy. Middle column: immunofluorescence, FITC. Right column:
overlay of left and middle column. Row (A): activated protoscoleces. Row (B): freeze fracture section of activated protoscoleces. Scale bar = 100 μm. Row (C):
adult worms. Scale bar = 4 mm.
Results
E. multilocularis protoscoleces were isolated from infected
Meriones unguiculatus voles and labeled with the monoclonal
antibody MAbEmA9. Fluorescence detection was mediated by
a FITC-conjugated anti-mouse monoclonal antibody. After ac-
tivating the protoscoleces with acid-bile-pancreatin, a distinct
staining of protoscoleces heads could be observed (Figure 1A).
Specific antibody binding was not observed in preparations
without the monoclonal antibody (conjugate control) or using
an unrelated commercial mouse IgG3 antibody as control (data
not shown). In freeze fracture sections, a surface location of the
corresponding epitope was evident (Figure 1B). Interestingly,
in adult E. multilocularis an intensive staining of the whole
worm was observed (Figure 1C). These data indicate a regu-
lated expression of the E. multilocularis EmA9 antigen during
development from the larval stages to the adult worm.
The EmA9 antigen was purified from adult worm tegument
preparations (Staebler et al. 2006) using an immuno-affinity
column prepared with the MAbEmA9. Multiple column eluates
were combined and subjected to size-exclusion chromatogra-
phy. The antigen was detected by ELISA of aliquots from col-
lected fractions. As shown in Figure 2, the antigen eluted from
the size-exclusion column as a broad peak, indicating struc-
tural heterogeneity of the antigen. The main fractions eluting at
600 kDa were pooled for further analyses.
Fig. 2. Size-exclusion chromatography of the EmA9 antigen. One milliliter of
fractions was collected and screened by sandwich- ELISA using the
monoclonal antibody MAbEmA9. The elution positions of molecular mass
standards are indicated with the corresponding molecular weight values.
Crude and purified EmA9 antigen preparations were sub-
jected to sodium periodate oxidation and their reactivities with
selected antibodies were assessed by ELISA. Upon oxidation,
a clear decrease in signal intensity was observed with both
polyclonal chicken anti-tegument antibodies and MAbEmA9,
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Fig. 3. Sandwich-ELISA analysis of the periodate-oxidized EmA9 antigen.
Left: crude E. multilocularis tegumental antigen preparation detected with a
polyclonal chicken anti-tegument antibody. Middle: the purified EmA9 antigen
detected with a polyclonal chicken anti-tegument antibody. Right: the purified
EmA9 antigen detected with the monoclonal antibody MAbEmA9. Black bars:
without periodate oxidation; gray bars: antigens were subjected to periodate
oxidation prior to ELISA analysis. Results are means of duplicate samples.
indicating that carbohydrates constitute major epitopes for these
antibodies (Figure 3).
Nonreductive β-elimination of the purified EmA9 antigen re-
sulted in a significant decrease of threonine in the amino acid
composition, indicating the presence of O-linked glycans at-
tached to the hydroxyamino acid (99.8% confidence, Table I).
The amount of serine also appeared to be lowered, suggesting
a second O-glycosylation type of the antigen. However, with a
p-value of 0.1648 and a risk level of 0.05, the data do not sup-
port a significant decay of serine after β-elimination. Carbohy-
drate compositional analyses by high-performance liquid chro-
matography showed that the major carbohydrate constituents of
the EmA9 antigen are derived from GlcNAc and Gal, together
with significant amounts of Fuc, Man, and GalNAc. The mo-
lar ratio of Man:GlcNAc:GalNAc:Gal:Fuc was calculated to be
8:21:1:14:3, and the ratio of carbohydrate to protein was found
to be 1.5:1 (w/w).
Glycans were released from the EmA9 antigen by hydrazi-
nolysis under conditions, which release O-glycans as well as N-
glycans (Patel et al. 1993). The liberated glycans were labeled
with 2-aminobenzamide (2AB) and analyzed by NP-HPLC. Re-
tention times were calibrated with 2AB-labeled dextran hydro-
sylate and converted into glucose units (GU) (Grubenmann et al.
2004). An unfractionated, 2AB-labeled sample aliquot was sub-
jected to MALDI-TOF-MS and nine different saccharide com-
positions could be assigned (S2–S10, Table II). A comparison of
fluorescence profiles of glycans released under N- and O-glycan
liberating conditions with O-glycan only condition indicated
the presence of N-glycosylation by the appearance of additional
peaks, eluting >5 GU in the N- and O-glycan releasing condi-
tion (data not shown). For subsequent analyses, hydrazinolysis
conditions liberating N- and O-glycans were used (Figure 4).
GU values were directly assigned to mass determinations from
collected NP-HPLC fractions for the saccharide compositions
Table I. Results of the amino acid and monosaccharide analyses of the EmA9
antigen
Before β- After β-
elimination elimination
Component mol%a mol%a p-value
Asx 5.4 ± 0.68 4.6 ± 0.32 0.1256
Glx 5.3 ± 0.49 4.7 ± 0.53 0.2030
Ser 4.1 ± 0.07 3.3 ± 0.77 0.1648
His 1.1 ± 0.12 1.0 ± 0.09 0.6371
Gly 4.4 ± 0.63 4.1 ± 0.81 0.6283
Thr 5.6 ± 0.40 3.6 ± 0.28 0.0017
Ala/Arg 14.8 ± 1.33 11.7 ± 1.59 0.0621
Tyr 1.1 ± 0.10 1.0 ± 0.41 0.7001
Val 2.4 ± 0.20 2.4 ± 0.40 0.8924
Met 0.0 0.0
Phe 1.5 ± 0.05 1.4 ± 0.15 0.6972
Ile 0.0 0.0
Leu 4.2 ± 0.08 3.7 ± 0.61 0.1948
Lys n.d. n.d.
Pro 2.9 ± 0.18 2.5 ± 0.35 0.1162
Man 7.9 ± 0.88
GlcN 21.1 ± 1.31
GalN 1.0 ± 0.20
Gal 14.2 ± 1.53
Fuc 2.9 ± 0.24
aThe data are background-corrected. Values are means ± SD, n = 3, n.d. = not
detected. Statistical significance was calculated using the two-tailed Student’s
t-test model with the null hypothesis that the amounts of each amino acid are
equal before and after β-elimination. N-Acetyl hexosamines were detected as
their de-N-acetylated derivatives, respectively glucosamine (GlcN) and
galactosamine (GalN).
Fig. 4. NP-HPLC analysis of 2AB-labeled EmA9 O-linked and N-linked
oligosaccharides. The retention times were externally calibrated with
2AB-labeled standard glucose oligomers and converted to glucose units (GU).
Elution positions of the O-glycans S1–S4 and N-glycans S5–S11 are labeled.
5.93 GU corresponds to the elution time of a bi-antennary, core fucosylated
N-glycan.
Hex1HexNAc2, Hex1HexNAc3, and Hex1HexNAc4 with 2.61
GU, 3.18 GU, and 4.06 GU, respectively. From the 2.61 GU
and 3.18 GU, fractions collision-induced fragmentation spectra
could be obtained by MALDI-TOF/TOF-MS, and the sequences
HexNAc-HexNAc-Hex-2AB and HexNAc-HexNAc-HexNAc-
Hex-2AB were assigned. Figure 5 shows the fragment spec-
trum of the saccharide S2 at 2.61 GU. The Y1-fragment ion
at m/z 323.1 corresponded to the 2AB-hexose and was also
evident in the fragment spectrum corresponding to saccharide
S3 (Table II). The Y2-fragment ion at m/z 526.2 was the most
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Table II. Summary of the data describing the O-linked structures S1-S4 and N-glycosylation of the EmA9 antigen
Fragment ions Reducing Structure
Designation m/z meas. m/z calc.  Mass Composition (m/z) JBBH end GU assignment
S1 + Gal 1.81 HexNAcβ-Gal
S2 729.280 729.282 0.002 Hex1HexNAc2 226, 244, 305,
323, 351, 429,
447, 508, 526
+ Gal 2.61 HexNAcβ-
HexNAcβ-Gal
S3 932.347 932.361 0.014 Hex1HexNAc3 226, 244, 323,
447, 526, 554, 729
+ Gal 3.18 HexNAcβ-
HexNAcβ-
HexNAcβ-Gal
S4 1135.431 1135.441 0.010 Hex1HexNAc4 + Gal 4.06 HexNAcβ-
HexNAcβ-
HexNAcβ-
HexNAcβ-Gal
S5 1377.472 1377.493 0.021 Hex5HexNAc2 226, 347, 364,
509, 567, 833,
874, 1036, 1215
Man5
S6 1402.518 1402.525 0.006 dHexHex3HexNAc3 226, 364, 510,
550, 713, 915,
1256
Mono-antennary,
core Fuc
S7 1605.589 1605.604 0.015 dHexHex3HexNAc4 364, 510, 538,
567, 713, 741,
915, 931, 1118,
1136, 1402, 1459
Bi-antennary, core
Fuc
S8 1751.657 1751.662 0.005 dHex2Hex3HexNAc4 364, 567, 713,
915, 1118, 1264,
1403
Bi-antennary, 1 x
Fuc, core Fuc
S9 1767.657 1767.657 0.000 dHexHex4HexNAc4 1264, 1280, 1462,
1621
Bi-antennary, 1
Gal, 1 Fuc
S10 1808.665 1808.684 0.019 dHexHex3HexNAc5 226, 364, 388,
510, 550, 713,
753, 915, 1118,
1321, 1402
Tri-antennary,
core Fuc
S11 2012.117 2011.763 0.354 dHexHex3HexNAc6 364, 567, 713,
915, 1321, 1524,
1606, 1809
Tetra-antennary,
core Fuc
MALDI-TOF/TOF-MS data: m/z meas.: measured values; m/z calc.: theoretical values;  mass: m/z value deviation measured from theoretical values; JBBH: Jack
bean beta-N-acetyl-hexosaminidase susceptibility, + susceptible to JBBH; reducing end saccharide analysis of JBBH digestion products subjected to RP-HPLC;
GU: glucose units determined by NP-HPLC.
Fig. 5. MALDI-TOF/TOF-MS of the O-glycan S2. The fragment spectrum
obtained from the peak fractions eluting at 2.61 GU (see Figure 4) together
with the assigned saccharide structure is shown. The main fragment ions are
labeled; M+Na+: precursor ion.
intense fragment ion in the spectrum and described the disac-
charide HexNAc-Hex-2AB. On the other hand, the abundant
B2-fragment ion at m/z 492.1 described the HexNAc-HexNAc
disaccharide. These two ions can only be generated from a linear
structure, suggesting the sequence HexNAc-HexNAc-Hex-2AB
for saccharide S2. Apparent Z1-, Z2-, C1-, and C2-type ions com-
plemented this assignment.
Peak fractions at 1.81 GU, 2.61 GU, 3.18 and 4.06 GU
corresponding to S1–S4 were digested with JBBH and re-
chromatographed by NP-HPLC (Figure 6). Susceptibility to
the Jack Bean enzyme could be observed with all four frac-
tions, indicating β-anomericity for the HexNAc constituents and
confirming the sequence assignments obtained from MALDI-
TOF/TOF-MS. 2AB-labeled chitobiose was treated in parallel
with the peak fractions and was completely converted to 2AB-
GlcNAc (data not shown). Reverse-phase chromatography of
the JBBH-treated fractions showed a co-elution of the reduc-
ing end hexose with 2AB-galactose, indicating that galactose
is the reducing end constituent in the EmA9 O-linked glycans.
As shown in Figure 7, 2AB-galactose derived from saccharide
S2 was clearly separated from 2AB-mannose, an alternative
candidate for the reducing end hexose (compare with Table I).
In unfractionated 2AB-labeled sample aliquots, m/z values
correlating to possible N-glycan structures were also acquired
(data not shown). However, after NP-HPLC separation, frag-
ment spectra could not be acquired from the collected peak
fractions, thus preventing a direct GU and sequence assign-
ment to the m/z values. Therefore, the NP-HPLC fractions
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Fig. 6. Jack bean β-N-acetylhexosaminidase (JBBH) digestion. NP-HPLC of
fractions corresponding to S2 (top panel) and S3 (bottom panel) was
re-chromatographed after JBBH digestion (continuous line) or without JBBH
digestion (dotted line). Retention times are given in GU (see Figure 4).
Fig. 7. Reducing-end-saccharide analysis. The NP-HPLC peak fractions
corresponding to S2 before (dotted line) and after JBBH digestion were
analyzed by RP-HPLC. The elution positions of authentic 2AB-labeled
monosaccharides are marked with dots.
corresponding to the elution times of potential N-glycans (i.e.,
>4.2 GU) were pooled, desalted with porous graphitized sil-
ica, concentrated and re-analyzed by MALDI-TOF/TOF-MS.
Fragment spectra were acquired from oligomannose 5 (Man5)
and mono-, bi-, tri- and tetra-antennary-type N-glycan structures
(Table II). Apart from the Man5 glycan, all N-glycans contained
Fig. 8. MALDI-TOF/TOF-MS of the N-glycan S7. The fragment spectrum of
the precursor ion at m/z 1605.589 obtained from the pooled fractions of
S5–S11 (see Figure 4) together with the assigned N-glycan structure is shown.
The main fragment ions are labeled; M+Na+: precursor ion.
one or two fucoses and for all but structure S9, core fucosylation
was evidenced by the presence of fragment ions corresponding
to dHex-modified Y1 and/or Y2 fragments (Figure 8). The sec-
ond fucose in saccharide S8 might be attached to a terminal
HexNAc, as indicated by the presence of a B4 +dHex fragment
ion at m/z 1264 (Table II). In addition, fragment spectra from a
core fucosylated, tetra-antennary N-glycan at m/z 2012 could be
acquired (S11, Table II). The presence of bisecting N-glycans
in the acquired spectra cannot be excluded. However, the flu-
orescence peak at 5.93 GU could be assigned to structure S7
and would be in good agreement with 5.90 and 5.93 GU values
described before for bi-antennary core fucosylated N-glycans
(see Figure 4) (Rudd et al. 1999, 2001).
Discussion
In recent years, a large amount of structural data on helminth-
derived glycans has become available due to the application
of sensitive and sophisticated analytical techniques primarily
HPLC, NMR, and mass spectrometry (Huang et al. 2001). The
diverse array of defined oligosaccharide elements includes both
N- and O-glycans of surface and secreted glycoconjugates most
of which induce strong antibody responses in parasitized hosts
(Khoo and Dell 2001). The glycans in helminth glycoproteins
possess structures resembling in many ways those found in
higher organisms, but frequently these molecules are specifi-
cally modified resulting in a range of novel carbohydrate archi-
tectures (Hokke and Deelder 2001). The present study describes
the glycan structures of a surface antigen expressed by the adult
stages of E. multilocularis. This antigen is recognized by the
monoclonal antibody EmA9 that has been used as a tool in co-
proantigen diagnosis of canine echinococcosis (Nonaka et al.
1998). A strong surface expression of the EmA9 antigen could
be detected in the adult stages of E. multilocularis, whereas only
the heads were stained in activated protoscoleces (Figure 1).
This is the first observation of the EmA9 epitope in the larval life
cycle stage, indicating a developmentally regulated expression
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of this antigen. The clear decrease in the immunoreactivity of
the EmA9 antigen following periodate oxidation confirmed an
association of its antigenic character with glycan structures.
Subsequent chemical and statistical analyses showed that the
majority of these glycans are O-linked to threonine residues of
the peptide backbone. GlcNAc and Gal are the dominant sugar
constituents with Gal at the reducing termini. Gal-α-Ser/Thr
linkages, extended with one or two alpha-linked Gal, have been
reported to occur in cuticle collagens of free living earth- and
clamworms (Spiro 2002). The molar percentage of Gly in the
amino acid composition of the purified EmA9 antigen speaks
against the possibility of a collagen domain in the antigen. Ad-
ditional peptide sequencing and nucleotide cloning experiments
would be required to unravel the identity of the peptide back-
bone. Further, the anomericity of the Gal to Thr linkage in the
EmA9 antigen was not determined. Gal linked in β-anomericity
to a peptide backbone has only been described in linkages to
hydroxylysine or hydroxyproline (Spiro 2002), and a Gal-β-
Thr linkage in the EmA9 antigen would establish a novel type
of O-glycosylation core structure. Such investigations require
large-scale purification of the EmA9 antigen and corresponding
glycopeptides followed by enzymatic deglycosylation analyses.
O-Linked Gal appears generally much less widely dispersed
in nature than mucin-type GalNAc-Ser/Thr or the GlcNAc-
Ser/Thr linkage. Recently, a single O-linked tri-saccharide struc-
ture with galactose at the reducing end and elongated with
GlcNAc and terminal Gal was described in Schistosoma man-
soni, whereas the majority of O-glycosylation was attributed
to mucin-type glycosylation (Jang-Lee et al. 2007). GalNAc-
Ser/Thr linkages were not found in the EmA9 antigen, and this
glycoprotein differs significantly in its glycoconjugate com-
position compared to the mucin-type O-glycosylation of the
Em2(G11) surface glycoprotein expressed by the E. multiloc-
ularis larval stage. An unusual feature of the EmA9 antigen
glycoprotein is the presence of β-HexNAc extensions of re-
ducing end Gal residues. By correlating the high abundance of
GlcNAc in the carbohydrate compositional analyses with the
major fluorescence peaks of the 2AB-labeled EmA9 antigen
saccharides, it can be suggested that β-GlcNAc residues are ex-
tending the reducing end Gal residues. To our knowledge, these
O-linked glycoconjugate structures do not have precedence in
any other species described in the literature. N-Linked glycans
have also been detected with mono-, bi-, tri- and tetra-antennary-
type structures, most of which were found to be core-fucosylated
and not distinguished by novel structural features. The terminal
fucose residue in the N-glycan structure S8 might mimik blood
group Lewisa or Lewisx motives and mediate cellular interac-
tions in the host intestine in support of the manifestation of
the parasite infection. Lewisx epitope bearing glycoconjugates
have been described in detergent extracts of the parasitic ne-
matode Dictyocaulus viviparus and in antigens derived from
parasitic trematodes Schistosoma spp. and were implicated
in immunomodulatory host responses during establishment
of schistosome infection in mice (Velupillai and Harn 1994;
Haslam et al. 2000; Nyame et al. 2004).
Previously, a major surface antigen, stage-specifically ex-
pressed by the larval stage of E. multilocularis, has been charac-
terized as a mucin-type O-glycosylated protein (Hu¨lsmeier et al.
2002). The glycans of this Em2(G11) antigen were found to con-
tain novel linear and branched oligosaccharide structures that
differ from the adult stage antigen in containing Gal and GalNAc
as major constituents with GalNAc being the sole reducing end
saccharide. Furthermore, in contrast to the adult stage EmA9
antigen, N-linked glycosylation was not found in the larval stage
Em2(G11) antigen (Hu¨lsmeier et al. 2002). Other studies have
shown that the adult stages of the dog tapeworm E. granulosus
also contain epitopes recognized by the MAbEmA9 (Malgor
et al. 1997), and indirect methods using lectin binding have
identified carbohydrate structures in the tegument and other tis-
sues of this closely related parasite with Gal, GalNAc, and Man
as major glycan constituents (Casaravilla et al. 2003). A similar
carbohydrate composition pattern appears to be present in other
tapeworms including Taenia taeniaeformis and Hymenolepis
diminuta, but the structures of these glycans have also not been
defined (Casaravilla et al. 2003). The most extensively and best
studied helminth antigenic glycan structures are those carried
by schistosomes. These parasites synthesize O-glycans ranging
from short mucin-type saccharides to highly complex O-glycans
containing multifucosylated unusual structural elements (Hokke
and Deelder 2001). In addition, various stages of this parasite
express glycoproteins carrying both, simple and more complex
multi-antennary N-linked glycans. Many of this great variety of
structures have been chemically defined. Interestingly, the gly-
cans of Echinococcus and other cestode antigens show some
resemblance to the cancer-associated simple O-glycosylated
antigens (Alvarez Errico et al. 2001). Glycoproteins contain-
ing these truncated O-glycans, such as the Tn (αGalNAc-O-R),
TF (βGal1,3-αGalNAc-O-R), and Tk [GlcNAcβ1-6(GlcNAcβ1-
3)Gal-O-R] structures, seem to be widely expressed in helminths
(Osinaga 2007; Ubillos et al. 2007).
The precise physiological functions of helminth glycoconju-
gates are still unclear. Previous studies have shown that immune
responses against various helminth species in infected hosts are
mainly directed toward glycan structures of surface or secreted
glycoconjugates (Ferreira et al. 2000; Nyame et al. 2004). These
macromolecules are therefore believed to play critical roles in
host-parasite interactions including host recognition, attachment
to host tissues, protection of vital tegumental structures, and im-
mune evasion. Like most of the helminth glycoconjugates, the
biological role of the EmA9 antigen in the host-parasite in-
terplay is unknown, but the observation that this molecule is
developmentally upregulated in the maturing larvae suggests
that it plays an important role in the establishment of the para-
site in its host and success of the infection. The present study
may be a first step toward a better understanding of the interac-
tion between the tapeworm EmA9 antigen and its canine host
at the molecular level. The striking differences in glycosylation
of the adult versus larval stage antigens reflect an adaptation to
the dramatic environmental changes from the definite (canine,
small intestine) to the intermediate (rodent, liver) host during
the life cycle of E. multilocularis.
Material and methods
Immunofluerescence labeling of larval stages and adult worms
Adult stage worms were collected from naturally infected foxes
(Deplazes et al. 1999) and conserved with 5% buffered for-
malin until further processing. E. multilocularis larval stages
(protoscoleces) were isolated from infected Meriones un-
guiculatus voles and used for immunnofluorescence stain-
ing after acid-bile-pancreatin-mediated activation in liquid
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preparations or in freeze fracture sections (Thompson et al.
1990). Protoscoleces were stained with and without prior for-
malin fixation and no differences could be observed in the
staining pattern. Formalin-fixed specimens were treated with
50 mM ammonium chloride and 5% fetal calf serum (FCS)
in PBS for 20 min and 30 min at room temperature, respec-
tively, and subsequently incubated with the IgG3 monoclonal
antibody MAbEmA9 (5 μg/mL PBS) (Kohno et al. 1995) or
with 5 μg/mL PBS of an unrelated purified IgG3 MAb (I3784,
Sigma-Aldrich, St. Louis, MO) for 1 h at 37◦C. The specimens
were washed twice with 5% FCS in PBS and incubated with
an anti-mouse FITC conjugated secondary antibody (goat anti-
mouse IgA, IgG, IgM, F 1010, Sigma), diluted 1:500 in 5% FCS
in PBS, for 1 h at 37◦C. Then, the specimens were washed once
with 5% FCS in PBS and directly examined by fluorescence mi-
croscopy (in all experiments conjugate controls without MAbs
were performed to confirm specific antibody reactions).
Size-exclusion chromatography
The E. multilocularis EmA9 antigen was immunoaffinity puri-
fied using the monoclonal antibody MAbEmA9 coupled with
CNBr-activated Sepharose. The column was prepared accord-
ing to the manufacturers’ instructions and the eluted antigen was
subjected to Superdex 200 HR (GE Healthcare) gel-filtration as
described (Hu¨lsmeier et al. 2002).
Amino acid analysis and carbohydrate compositional analyses
Amino acid analysis and nonreductive β-elimination were per-
formed as previously described (Hu¨lsmeier et al. 2002). Changes
in amino acid composition were statistically validated using the
two-tailed Student’s t-test model with a risk level of α= 0.05 and
a degree of freedom calculated as d f = (nbefore + nafter) − 2 = 4.
The t-values were calculated with t = ¯Xbefore− ¯Xafter√
SD2before
nbefore
+ SD
2
after
nafter
.
Carbohydrate analyses were carried out by reversed-
phase HPLC of 1-phenyl-3-methyl-5-pyrazolone derivatized
monosaccharides (Honda et al. 1989; Fu and O’Neill 1995).
Aliquots of purified EmA9 antigen preparation were pre-mixed
with 1 nmol lyxose internal standard each. For each batch
of samples, two standards of 0.5–1 nmol of mannose (Man),
lyxose, N-acetylglucosamine (GlcNAc), N-acetylgalactosamine
(GalNAc), glucose, galactose (Gal), xylose, and fucose were
prepared. The antigen and standard samples were hydrolyzed
in 100 μL of 2 M trifluoroacetic acid (TFA) for 4 h at 100◦C
in a 0.8 mL crimp top glass vial. The samples were dried in
a rotary evaporator and washed with 100 μL of 2-propanol
followed by evaporation. Then, 20 μL of 0.5 M 1-phenyl-3-
methyl-5-pyrazolone in methanol and 20 μL of 0.3 M NaOH
were added and the samples were incubated for 40 min at 70◦C.
After cooling to room temperature, the samples were neutral-
ized with 10 μL of 0.6 M HCl and vacuum dried to remove
methanol. The samples were re-dissolved in 100 μL water and
extracted four times with 200 μL dibutyl ether. The upper or-
ganic phase was discarded and 10–60% of the sample were
analyzed by reversed-phase HPLC using a Vydac 208TP53,
300 ˚A, C8, 3.2 × 250 mm column, and UV detection at 245 nm.
Buffer A was 10% acetonitrile in 50 mM sodium acetate, pH
4.7, buffer B was 25% acetonitrile in 50 mM sodium acetate,
pH 4.7, and buffer C was 80% acetonitrile in water.
The following program was used.
Time Flow
(min) % Buffer A % Buffer B % Buffer C (mL/min)
0.0 100 1.0
8.0 100 0.5
10.0 80 20
48.0 100
53.0 100
53.1 100
56.0 100
56.1 100
61.0 100
Molecular relative response factors versus the lyxose inter-
nal standard were calculated for each monosaccharide and the
amounts of each monosaccharide in the sample were calculated
with respect to the response factor in relation to the lyxose
internal standard in the sample.
Periodate oxidation
Aliquots of crude or purified EmA9 antigen fractions were in-
cubated in 50 mM sodium meta-periodate in PBS in the dark for
3 h at room temperature. An equal volume of freshly prepared
1 M sodium borohydride was added, and the reaction mixture
was incubated for 1 h at room temperature. The antigen prepara-
tions were dialyzed against PBS and subjected to ELISA antigen
detection as described (Deplazes et al. 1992).
Hydrazinolysis
The purified EmA9 antigen was extensively dialyzed against
0.1% TFA at 4◦C, lyophilized, and subjected to hydrazinoly-
sis for 4 h at 95◦C as described (Patel et al. 1993). For re-N-
acetylation of hexosamines, acetic acid anhydride was added
to ice cold, saturated sodium bicarbonate dissolved reaction
products. Reducing end acetylations were removed by passage
through 3 mL Dowex AG50 resin and incubation in 2 mL of
1 mM copper acetate in 1 mM acetic acid for 1 h at room tem-
perature. Liberated oligosaccharides were purified by passage
through 2 mL ODS resin over 1 mL Dowex AG50 and subjected
to 2-amino benzamide (2AB) labeling and normal-phase (NP)
HPLC analyses as described earlier (Grubenmann et al. 2004).
Mass spectrometry
The MALDI matrix was prepared by suspending 10 mg DHB
in 1 mL of 50% acetonitrile, containing 1 mM NaCl. The sam-
ple and matrix were mixed on the MALDI plate at a ratio of
1:1 and allowed to dry at room temperature. The dried spots
were re-crystallized by applying <0.1 μL ethanol. MALDI mass
spectra were recorded in positive ion mode, using an Applied
Biosystems 4700 Proteomics Analyzer (Applied Biosystems).
Averages of 2000–5000 laser shots were used to obtain MS/MS
spectra. The collision energy was set at 1 kV and the air pressure
inside the collision cell was set at 2 × 10−6 Torr.
Jack bean β-N-acetylhexosaminidase (JBBH) digestions
Two equal aliquots per pooled peak fractions collected from NP-
HPLC were dried by rotary evaporation. One tube was subjected
to JBBH (Prozyme) digestion and the other tube was incubated
in the digestion buffer only. Enzymatic digestion was carried out
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in 20 μL volumes of 0.1 M sodium acetate buffer, pH 5.5, and
10 U JBBH per mL. The digestion mixture was overlaid with
10 μL mineral oil and incubated at 37◦C for 16 h. The reaction
products were re-analyzed by NP-HPLC.
Reducing end saccharide analysis
The 2AB-saccharide fractions obtained after JBBH digestion
were applied to reverse-phase chromatography on a Hypersil
ODS column, 4.6 × 150 mm, 3 μm particle size (Thermo Elec-
tron Corporation) and eluted using a trinary solvent gradient
system at a flow rate of 0.8 mL/min at 40◦C. Buffer A was
50 mM sodium acetate, pH 4.7, buffer B was buffer A with 10%
acetonitrile, and buffer C was 100% acetonitrile.
The following program was used.
Time (min) % Buffer A % Buffer B % Buffer C
0.0 100
10.0 100
70.0 85 15
80.0 20 80
90.0 20 80
100.0 100
120.0 100
The elution positions of authentic 2AB-monosaccharide
derivatives were determined prior and post-sample application
(Chiba et al. 1997).
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